In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems - Université de Bretagne Occidentale Access content directly
Journal Articles Thrombosis Research Year : 2018

In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems

Domains

Life Sciences [q-bio] Human health and pathology Bioengineering Nuclear medicine

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02057877

Submitted on : Tuesday, March 5, 2019-4:23:57 PM

Last modification on : Tuesday, October 3, 2023-10:38:03 AM

No file

Dates and versions

hal-02057877 , version 1 (05-03-2019)

Identifiers

Cite

Philippe Robin, Srishti Kumar, Pierre-Yves Salaun, Pierre-Yves Le Roux, Francis Couturaud, et al.. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thrombosis Research, 2018, 171, pp.97-102. ⟨10.1016/j.thromres.2018.09.050⟩. ⟨hal-02057877⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST GETBO USPC IBSAM UP-SANTE
28 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More